Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies

BACKGROUND: Corticosteroid sparing is required in 15% to 40% of adults with persistent or chronic primary immune thrombocytopenic purpura (ITP). Herein, the efficacy of immunomodulatory drugs (dapsone, interferon alpha, danazol, and hydroxychloroquine as second-third-line therapies in ITP is investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Emmanuelle, Reynaud, Quitterie, Fort, Romain, Durupt, Stéphane, Cathébras, Pascal, Durieu, Isabelle, Lega, Jean-Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604622/
https://www.ncbi.nlm.nih.gov/pubmed/28906353
http://dx.doi.org/10.1097/MD.0000000000007534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604622/
https://www.ncbi.nlm.nih.gov/pubmed/28906353
http://dx.doi.org/10.1097/MD.0000000000007534

Ejemplares similares